Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bergh

Showing results (171-180 of 233) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|January 2, 1992
Characterization of a U-937 subline which can be induced to differentiate in serum-free mediumF Oberg, N Hult, U Bjare, et al.
Life Sciences|August 26, 1999
p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of haloperidolL J Mienie, J J Bergh, J R Bloomquist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancersJ Li, J Holm, J Bergh, et al.
Medical Oncology (Northwood, London, England)|January 9, 2009
Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factorB Linderholm, J Bergqvist, H Hellborg, et al.
Acta Oncologica (Stockholm, Sweden)|September 15, 2000
Can axillary dissection be avoided by improved molecular biological diagnosis?T Lindahl, G Engel, J Ahlgren, et al.
British Journal of Cancer|March 25, 2000
Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancerT Erselcan, K J Kairemo, T A Wiklund, et al.
Academic Radiology|September 1, 1996
Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trialE L Siegel, J D Rosenblum, D A Eckard, et al.
Genes, Chromosomes & Cancer|July 1, 1992
Characterization of the submicroscopic deletion in the small-cell lung carcinoma (SCLC) cell line U2020H A Drabkin, M J Mendez, P H Rabbitts, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of tauromustine administered in a weekly scheduleS B Gjedde, H T Mouridsen, E L-Madsen, et al.
Statistics in Medicine|May 26, 2004
Gene expression profiling for prognosis using Cox regressionY Pawitan, J Bjöhle, S Wedren, et al.
Pageof 24

Showing results (171-180 of 233) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|January 2, 1992
Characterization of a U-937 subline which can be induced to differentiate in serum-free mediumF Oberg, N Hult, U Bjare, et al.
Life Sciences|August 26, 1999
p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of haloperidolL J Mienie, J J Bergh, J R Bloomquist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancersJ Li, J Holm, J Bergh, et al.
Medical Oncology (Northwood, London, England)|January 9, 2009
Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factorB Linderholm, J Bergqvist, H Hellborg, et al.
Acta Oncologica (Stockholm, Sweden)|September 15, 2000
Can axillary dissection be avoided by improved molecular biological diagnosis?T Lindahl, G Engel, J Ahlgren, et al.
British Journal of Cancer|March 25, 2000
Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancerT Erselcan, K J Kairemo, T A Wiklund, et al.
Academic Radiology|September 1, 1996
Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trialE L Siegel, J D Rosenblum, D A Eckard, et al.
Genes, Chromosomes & Cancer|July 1, 1992
Characterization of the submicroscopic deletion in the small-cell lung carcinoma (SCLC) cell line U2020H A Drabkin, M J Mendez, P H Rabbitts, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of tauromustine administered in a weekly scheduleS B Gjedde, H T Mouridsen, E L-Madsen, et al.
Statistics in Medicine|May 26, 2004
Gene expression profiling for prognosis using Cox regressionY Pawitan, J Bjöhle, S Wedren, et al.
Pageof 24